Evidence map›Paper›PMID 21569301›Full record

ArticleRetrovirology2011

A functional role for ADAM10 in human immunodeficiency virus type-1 replication.

Brian M Friedrich, James L Murray, Guangyu Li, Jinsong Sheng, Thomas W Hodge, Donald H Rubin, William A O'Brien, Monique R Ferguson

Open access · goldAbstract read
In one paragraph

Article in Retrovirology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Brian M FriedrichDepartment of Pathology, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77555, USA.
James L Murray
Guangyu Li
Jinsong Sheng
Thomas W Hodge
Donald H Rubin
William A O'Brien
Monique R Ferguson
The University of Texas Medical Branch at Galveston · USVanderbilt University · USVA Tennessee Valley Healthcare System · US

Funding

Virology CoreP30AI036211 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI BUTEL, JANET S · 1994 to 2015
$21.7M
Role of Tetraspan Glycoproteins (CD63) in HIV ReplicationR01HL088999 · NHLBI · UNIVERSITY OF TEXAS MED BR GALVESTON · PI FERGUSON, MONIQUE REGAIL · 2006 to 2011
$2.5M
Characterization of Cellular Proteins Involved in HIV InfectionR43AI084705 · NIAID · ZIRUS, INC. · PI O'BRIEN, WILLIAM AUSTIN · 2009 to 2009
$431k
NHLBI NIH HHS HL088999NHLBI NIH HHS R01 HL088999NIAID NIH HHS AI084705NIAID NIH HHS P30 AI036211NIAID NIH HHS R43 AI084705
6 · The paper itself

Abstract

backgroundGene trap insertional mutagenesis was used as a high-throughput approach to discover cellular genes participating in viral infection by screening libraries of cells selected for survival from lytic infection with a variety of viruses. Cells harboring a disrupted ADAM10 (A Disintegrin and Metalloprotease 10) allele survived reovirus infection, and subsequently ADAM10 was shown by RNA interference to be important for replication of HIV-1.

resultsSilencing ADAM10 expression with small interfering RNA (siRNA) 48 hours before infection significantly inhibited HIV-1 replication in primary human monocyte-derived macrophages and in CD4⁺ cell lines. In agreement, ADAM10 over-expression significantly increased HIV-1 replication. ADAM10 down-regulation did not inhibit viral reverse transcription, indicating that viral entry and uncoating are also independent of ADAM10 expression. Integration of HIV-1 cDNA was reduced in ADAM10 down-regulated cells; however, concomitant 2-LTR circle formation was not detected, suggesting that HIV-1 does not enter the nucleus. Further, ADAM10 silencing inhibited downstream reporter gene expression and viral protein translation. Interestingly, we found that while the metalloprotease domain of ADAM10 is not required for HIV-1 replication, ADAM15 and γ-secretase (which proteolytically release the extracellular and intracellular domains of ADAM10 from the plasma membrane, respectively) do support productive infection.

conclusionsWe propose that ADAM10 facilitates replication at the level of nuclear trafficking. Collectively, our data support a model whereby ADAM10 is cleaved by ADAM15 and γ-secretase and that the ADAM10 intracellular domain directly facilitates HIV-1 nuclear trafficking. Thus, ADAM10 represents a novel cellular target class for development of antiretroviral drugs.

Indexed as

Host-Pathogen InteractionsVirus ReplicationActive Transport, Cell NucleusADAM10 ProteinADAM ProteinsAmyloid Precursor Protein SecretasesCells, CulturedHIV-1HumansMacrophagesMembrane ProteinsModels, BiologicalMutagenesis, InsertionalVirus IntegrationADAM10 ProteinADAM10 protein, humanADAM ProteinsAmyloid Precursor Protein SecretasesMembrane Proteins

Identifiers

PMID21569301
PMCPMC3118345
OpenAlexW2121365017

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.